Atlas Ventures startup Kymera Therapeutics lands $65M investment round

Cambridge startup Kymera Therapeutics Inc. has closed a $65 million Series B venture capital round Tuesday that will support the company as it prepares its first cancer and inflammatory disease drugs for the clinic.

Source: bizjournals.com Health Care:Biotechnology headlines - November 13, 2018 Category: Biotechnology Authors: Allison DeAngelis Source Type: news